The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells

J Cell Sci. 2004 Nov 1;117(Pt 23):5509-19. doi: 10.1242/jcs.01425. Epub 2004 Oct 19.

Abstract

Rotaviruses constitute a major cause of diarrhea in young mammals. Rotaviruses utilize different integrins as cell receptors, therefore upon their arrival to the intestinal lumen their integrin receptors will be hidden below the tight junction (TJ), on the basolateral membrane. Here we have studied whether the rotavirus outer capsid proteins are capable of opening the paracellular space sealed by the TJ. From the outermost layer of proteins of the rotavirus, 60 spikes formed of protein VP4 are projected. VP4 is essential for virus-cell interactions and is cleaved by trypsin into peptides VP5 and VP8. Here we found that when these peptides are added to confluent epithelial monolayers (Madin-Darby canine kidney cells), VP8 is capable of diminishing in a dose dependent and reversible manner the transepithelial electrical resistance. VP5 exerted no effect. VP8 can also inhibit the development of newly formed TJs in a Ca-switch assay. Treatment with VP8 augments the paracellular passage of non-ionic tracers, allows the diffusion of a fluorescent lipid probe and the apical surface protein GP135, from the luminal to the lateral membrane, and triggers the movement of the basolateral proteins Na+-K+-ATPase, alphanubeta3 integrin and beta1 integrin subunit, to the apical surface. VP8 generates a freeze-fracture pattern of TJs characterized by the appearance of loose end filaments, that correlates with an altered distribution of several TJ proteins. VP8 given orally to diabetic rats allows the enteral administration of insulin, thus indicating that it can be employed to modulate epithelial permeability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Amino Acid Sequence
  • Animals
  • Cell Membrane Permeability / drug effects
  • Cell Membrane Permeability / physiology
  • Claudin-3
  • Diabetes Mellitus, Type 1 / drug therapy
  • Disease Models, Animal
  • Dogs
  • Electric Impedance
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Epithelial Cells / ultrastructure
  • Freeze Fracturing
  • Hypoglycemic Agents / pharmacokinetics
  • Insulin / pharmacokinetics
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism*
  • Male
  • Membrane Proteins / metabolism
  • Molecular Sequence Data
  • Occludin
  • Phosphoproteins / metabolism
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism
  • RNA-Binding Proteins / pharmacology*
  • Rats
  • Rats, Wistar
  • Tight Junctions / drug effects*
  • Tight Junctions / metabolism*
  • Tight Junctions / ultrastructure
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / metabolism
  • Viral Nonstructural Proteins / pharmacology*
  • Zonula Occludens-1 Protein

Substances

  • Claudin-3
  • Cldn3 protein, rat
  • Hypoglycemic Agents
  • Insulin
  • Membrane Proteins
  • Occludin
  • Ocln protein, rat
  • Phosphoproteins
  • RNA-Binding Proteins
  • Tjp1 protein, rat
  • Viral Nonstructural Proteins
  • Zonula Occludens-1 Protein
  • NS35 protein, rotavirus